Opposite effects of clozapine and sulpiride on the lipopolysaccharide-induced inhibition of the GR-mediated gene transcription in fibroblast cells

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1153-1158

  Basta Kaim, Agnieszka ^b   Budziszewska, Bogusława ^b   Jaworska Feil, Lucylla ^b   Leśkiewicz, Monika ^b   Tetich, Magdalena ^b   Kubera, Marta ^b   Scharpe, Simon ^a   Lasoń, Władysław ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Clozapine; GR mediated gene transcription; Lipopolysaccharide; Sulpiride

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CLOZAPINE; CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; NEUROLEPTIC AGENT; PHOSPHOTRANSFERASE; SULPIRIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG USE; ENZYME ACTIVITY; FIBROBLAST; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MOLECULAR STABILITY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PLASMID; PROTEIN FUNCTION; REGULATORY MECHANISM; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TIME; TRANSCRIPTION REGULATION;

ANIMALS; CELL SURVIVAL; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CLOZAPINE; CORTICOSTERONE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; L CELLS (CELL LINE); LIPOPOLYSACCHARIDES; MICE; RECEPTORS, GLUCOCORTICOID; SULPIRIDE; TRANSCRIPTION, GENETIC;

EID: 1642421049     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Altamura A.C., Boin F., Maes M: HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur. Neuropsychopharmacol., 1999, 10, 1-4.
2. Bantel H., Schmitz M.L., Raible A., Gregor M., Schulze-Osthoff K.: Critical role of nuclear factor-kB and stress-activated protein kinases in steroid unresponsiveness. FASEB J., 2002, 16, 1832-1834.
3. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Leśkiewicz M., Kubera M., Lasoń W.: Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium dependent manner. Neuropharmacology, 2002, 43, 1035-1043.
4. Basta-Kaim A., Kubera M., Budziszewska B., Siwanowicz J., Lasoń W.: Effect of some antipsychotic drugs on immunoreactivity in C57BL/6 mice. Pol. J. Pharmacol., 2002, 54, 737-742.
5. Beaudry G., Langlois M.C., Weppe L, Rouillard C., Levesque D.: Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem., 2000, 75, 1694-1702.
6. Berrettini W.H., Nadi N.S., Gershon E.S.: Absence of specific binding of several putative neurotransmitters to human fibroblasts. J. Recept. Res., 1983, 3, 409-421.
7. Budziszewska B., Jaworska-Feil L., Kajta M., Lasoń W.: Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Brit. J. Pharmacol., 2000, 130, 1358-1393.
8. Conrad P.W., Millhorn D.E., Beitner-Johnson D.: Novel regulation of p38gamma by dopamine D2 receptors during hypoxia. Cell. Signal., 2000, 12, 463-467.
9. Dwivedi Y., Pandey G.N.: Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain. J. Pharmacol. Exp. Ther., 2000, 295, 244-254.
10. Dwivedi Y., Rizavi H.S., Pandey G.N.: Defferential effects of haloperidol and clozapine on [(3)H]camp binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J. Pharmacol. Exp. Ther., 2002, 301, 197-209.
11. Farooqui S.M., Prasad C.: An antibody to dopamine D2 receptor inhibits dopamine antagonist and agonist binding to dopamine D2 receptor cDNA transfected mouse fibroblast cells. Life Sci., 1992, 51, 1509-1516.
12. Forestier C., Moreno E., Meresse S., Phalipon A., Olive D., Sansonetti P., Gorvel J.P.: Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect. Immun., 1999, 67, 4048-4054.
13. Giambalvo C.T.: Protein kinase C and dopamine transport-2. Effects of amphetamine in vitro. Neuropharmacology, 1992, 31, 1211-1222.
14. Grinevich V., Ma X.M., Herman J.P., Jezova D., Akmayev I., Aguilera G.: Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J. Neuroendocrinol., 2001, 13, 711-723.
15. Gur R.E., Pearlson G.D.: Neuroimaging in schizophrenia research. Schizophrenia Bull., 1993, 19, 337-353.
16. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., Adcock I.M.: p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol., 2002, 109, 649-657.
17. Jardemark K.E., Ninan I., Liang X., Wang R.Y.: Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex. Neuroscience, 2003, 118, 501-512.
18. Kontaken O., Lakso M., Wong G., Castren E.: Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology, 2002, 27, 152-162.
19. Kowalski J., Blada J., Kucia K., Madej A., Herman Z.S.: Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr. Res., 2001, 50, 169-175.
20. Krstic M.D., Rogatsky I., Yamamoto K.R., Garabedian M.J.: Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol., 1997, 17, 3947-3954.
21. Lammers C.H., Garcia-Borreguero D., Schmider J., Gotthard U., Dettling M., Holsboer F., Heuser I.J.E.: Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biol. Psychiat., 1995, 38, 803-807.
22. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
23. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., Miller A.H.: The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function. Endocrinology, 1999, 140, 4359-4366.
24. Pozzi L., Hakansson K., Usiello A., Borgkvist A., Lindskog M., Greengard P., Fisone G.: Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J. Neurochem., 2003, 96, 451-459.
25. Reddi K., Nair S.P., White P.A., Hodges S., Tabona P., Meghji S., Poole S., Wilson M., Henderson B.: Surface-associated material from the bacterium Actinobacillus actinomycetemcomitans contains a peptide which, in contast to lipopolysaccharide, directly stimulates fibroblast interleukin-6 gene transcription. Eur. J. Biochem., 1996, 236, 871-876.
26. Rogatsky I., Logan S.K., Garabedian M.J.: Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Nat. Acad. Sci. USA, 1998, 95, 2050-2055.
27. Sadouk M.B., Pelletier J.P., Tardif G., Kiansa K., Cloutier J.M., Martel-Pelletier J.: Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab. Invest., 1995, 73, 347-355.
28. Wiegers G.J., Reul J.M.: Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci., 1998, 19, 317-321.
29. Wik G., Wiesel F.A., Eneroth P., Sedvall G., Astrom G.: Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiat. Scand., 1986, 74, 161-167.
30. Wyatt R.J., Henter I.D.: The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J. Psychiat. Res., 1998, 32, 169-177.
31. Xing Z., Jordana M., Braciak T., Ohtoshi T., Gauldie J.: Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Amer. J. Respir. Cell Molec. Biol., 1993, 9, 255-263.